Checkmate Pharmaceuticals IPO

Checkmate Pharmaceuticals is a clinical stage biopharmaceutical company focused on activation of innate immunity to treat cancer.

Register for Details

For more details on financing and valuation for Checkmate Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Checkmate Pharmaceuticals's ticker symbol?

CMPI

Learn more about Checkmate Pharmaceuticals

Forge green plus iconForge green minus icon

What is Checkmate Pharmaceuticals funding to date?

Checkmate Pharmaceuticals has raised $82MM to date.
Forge green plus iconForge green minus icon

When was Checkmate Pharmaceuticals founded?

Checkmate Pharmaceuticals was founded in 2015.
Updated on: Jun 12, 2022